Free body composition screenings now available at Bor Health Center
Free body composition screenings now available at Bor Health Center
Free body composition screenings now available at Bor Health Center
The Bor Health Center is offering free body composition screenings to the public. Located on Oktyabrskaya Street, the service uses advanced equipment to assess health risks without requiring an appointment. Residents can drop in during working hours for a detailed check-up at no cost.
The polyclinic runs the screenings from Monday to Friday, between 8:00 AM and 3:00 PM. Visitors can use a bioelectrical body composition analyser to measure fat mass, protein levels, total body fluid, and mineral content. The process provides a clear picture of physical health in minutes.
Another device, the InBody analyser, checks stress levels, vascular age, and blood oxygen saturation. Together, these tests help identify obesity risks and other potential health concerns. After the screening, participants receive personalised advice on caloric intake and exercise.
The health center has not released exact figures on how many people have used the service since its launch. However, the free access and lack of booking requirements make it widely available to the local community.
The initiative aims to improve health equity by offering detailed body assessments without charge. Those who attend receive tailored recommendations based on their results. The service continues to operate weekly, with no prior registration needed.
Garlic, Vitamin C, and Chlorophyll Team Up for Heart Health Breakthrough
Could a simple blend of garlic, vitamin C, and chlorophyll be the key to a healthier heart? New findings reveal surprising benefits for blood pressure and beyond.
Chuck Norris, 86, hospitalized after medical emergency in Hawaii
From Walker, Texas Ranger to recent films, Norris never slowed down—until now. Fans worldwide await news after his sudden hospitalization.
Blood Test Breakthrough Could Detect Hidden Artery Disease Years Earlier
A simple blood test could soon reveal invisible plaque buildup—long before it triggers a deadly event. Machine learning cracked the code in 45,000 patients' data.
Eli Lilly's retatrutide shows groundbreaking results in Type 2 diabetes trial
A triple-hormone drug could redefine diabetes care. Early data shows retatrutide outperforms competitors—but will regulators agree?